Effectiveness of revascularisation for the ulcerated foot in patients with diabetes and peripheral artery disease: A systematic review

Introduction Peripheral artery disease (PAD) is associated with an increased likelihood of delayed or non‐healing of a diabetes‐related foot ulcer, gangrene, and amputation. The selection of the most effective surgical technique for revascularisation of the lower limb in this population is challengi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes/metabolism research and reviews 2024-03, Vol.40 (3), p.e3700-n/a
Hauptverfasser: Chuter, Vivienne, Schaper, Nicolaas, Mills, Joseph, Hinchliffe, Robert, Russell, David, Azuma, Nobuyoshi, Behrendt, Christian‐Alexander, Boyko, Edward J., Conte, Michael S., Humphries, Misty D., Kirksey, Lee, McGinigle, Katharine C., Nikol, Sigrid, Nordanstig, Joakim, Rowe, Vincent, Berg, Jos C., Venermo, Maarit, Fitridge, Robert
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction Peripheral artery disease (PAD) is associated with an increased likelihood of delayed or non‐healing of a diabetes‐related foot ulcer, gangrene, and amputation. The selection of the most effective surgical technique for revascularisation of the lower limb in this population is challenging and there is a lack of conclusive evidence to support the choice of intervention. This systematic review aimed to determine, in people with diabetes and tissue loss, if direct revascularisation is superior to indirect revascularisation and if endovascular revascularisation is superior to open revascularisation for the outcomes of wound healing, minor or major amputation, and adverse events including mortality. Methods Title and searches of Medline, Embase, PubMed, and EBSCO were conducted from 1980 to 30th November 2022. Cohort and case‐control studies and randomised controlled trials reporting comparative outcomes of direct (angiosome) revascularisation (DR) and indirect revascularisation (IR) or the comparative outcomes of endovascular revascularisation and open or hybrid revascularisation for the outcomes of healing, minor amputation, and major amputation in people with diabetes, PAD and tissue loss (including foot ulcer and/or gangrene) were eligible. Methodological quality was assessed using the Cochrane risk‐of‐bias tool for randomised trials, the ROBINS‐I tool for non‐randomised studies, and Newcastle‐Ottawa Scale for observational and cohort studies where details regarding the allocation to intervention groups were not provided. Results From a total 7086 s retrieved, 26 studies met the inclusion criteria for the comparison of direct angiosome revascularisation (DR) and indirect revascularisation (IR), and 11 studies met the inclusion criteria for the comparison of endovascular and open revascularisation. One study was included in both comparisons. Of the included studies, 35 were observational (31 retrospective and 4 prospective cohorts) and 1 was a randomised controlled trial. Cohort study quality was variable and generally low, with common sources of bias related to heterogeneous participant populations and interventions and lack of reporting of or adjusting for confounding factors. The randomised controlled trial had a low risk of bias. For studies of DR and IR, results were variable, and it is uncertain if one technique is superior to the other for healing, prevention of minor or major amputation, or mortality. However, the majority of studies rep
ISSN:1520-7552
1520-7560
1520-7560
DOI:10.1002/dmrr.3700